NZ193236A - 2-(2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)derivatives of 2-hydroxy-benzoic acid or benzamide - Google Patents

2-(2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)derivatives of 2-hydroxy-benzoic acid or benzamide

Info

Publication number
NZ193236A
NZ193236A NZ193236A NZ19323680A NZ193236A NZ 193236 A NZ193236 A NZ 193236A NZ 193236 A NZ193236 A NZ 193236A NZ 19323680 A NZ19323680 A NZ 19323680A NZ 193236 A NZ193236 A NZ 193236A
Authority
NZ
New Zealand
Prior art keywords
benzodioxan
benzamide
ylmethyl
dihydro
hydroxy
Prior art date
Application number
NZ193236A
Other languages
English (en)
Inventor
J Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of NZ193236A publication Critical patent/NZ193236A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NZ193236A 1979-05-04 1980-03-24 2-(2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)derivatives of 2-hydroxy-benzoic acid or benzamide NZ193236A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,243 US4206125A (en) 1979-05-04 1979-05-04 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives

Publications (1)

Publication Number Publication Date
NZ193236A true NZ193236A (en) 1982-09-14

Family

ID=21887496

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ193236A NZ193236A (en) 1979-05-04 1980-03-24 2-(2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)derivatives of 2-hydroxy-benzoic acid or benzamide

Country Status (21)

Country Link
US (1) US4206125A (US06312121-20011106-C00033.png)
JP (1) JPS55147274A (US06312121-20011106-C00033.png)
AT (1) AT369365B (US06312121-20011106-C00033.png)
AU (1) AU531739B2 (US06312121-20011106-C00033.png)
BE (1) BE883087A (US06312121-20011106-C00033.png)
CA (1) CA1148963A (US06312121-20011106-C00033.png)
CH (1) CH645372A5 (US06312121-20011106-C00033.png)
DE (1) DE3014738A1 (US06312121-20011106-C00033.png)
DK (1) DK154503C (US06312121-20011106-C00033.png)
ES (1) ES490814A0 (US06312121-20011106-C00033.png)
FR (1) FR2455598A1 (US06312121-20011106-C00033.png)
GB (1) GB2051780B (US06312121-20011106-C00033.png)
IE (1) IE49564B1 (US06312121-20011106-C00033.png)
IL (1) IL59681A (US06312121-20011106-C00033.png)
IT (1) IT1127441B (US06312121-20011106-C00033.png)
NL (1) NL8002208A (US06312121-20011106-C00033.png)
NO (1) NO153572C (US06312121-20011106-C00033.png)
NZ (1) NZ193236A (US06312121-20011106-C00033.png)
PH (1) PH15963A (US06312121-20011106-C00033.png)
SE (1) SE434745B (US06312121-20011106-C00033.png)
ZA (1) ZA801603B (US06312121-20011106-C00033.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180746A (en) * 1989-02-17 1993-01-19 Takeda Chemical Industries, Ltd. Aralkylamine compounds

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204285B (en) * 1986-10-31 1991-12-30 Pfizer Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them
DE60315492T2 (de) * 2002-10-22 2008-04-24 Glaxo Group Ltd., Greenford Medizinisch verwendbare arylethanolamin verbindungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE635203A (US06312121-20011106-C00033.png) * 1962-07-20
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180746A (en) * 1989-02-17 1993-01-19 Takeda Chemical Industries, Ltd. Aralkylamine compounds

Also Published As

Publication number Publication date
IT1127441B (it) 1986-05-21
NL8002208A (nl) 1980-11-06
AT369365B (de) 1982-12-27
ZA801603B (en) 1981-03-25
IE800572L (en) 1980-11-04
IE49564B1 (en) 1985-10-30
ES8104997A1 (es) 1981-05-16
DK154503C (da) 1989-04-10
GB2051780A (en) 1981-01-21
FR2455598A1 (fr) 1980-11-28
AU531739B2 (en) 1983-09-01
AU5707780A (en) 1980-11-06
DE3014738A1 (de) 1980-11-13
GB2051780B (en) 1982-12-22
IL59681A (en) 1984-04-30
PH15963A (en) 1983-05-04
SE434745B (sv) 1984-08-13
DK154503B (da) 1988-11-21
CH645372A5 (de) 1984-09-28
JPS55147274A (en) 1980-11-17
JPS642115B2 (US06312121-20011106-C00033.png) 1989-01-13
BE883087A (fr) 1980-09-01
IT8048373A0 (it) 1980-04-09
ATA232780A (de) 1982-05-15
ES490814A0 (es) 1981-05-16
US4206125A (en) 1980-06-03
NO801296L (no) 1980-11-05
NO153572B (no) 1986-01-06
NO153572C (no) 1986-04-16
FR2455598B1 (US06312121-20011106-C00033.png) 1983-05-27
DK193580A (da) 1980-11-05
SE8003243L (sv) 1980-11-05
DE3014738C2 (US06312121-20011106-C00033.png) 1989-08-03
IL59681A0 (en) 1980-06-30
CA1148963A (en) 1983-06-28

Similar Documents

Publication Publication Date Title
ES516648A0 (es) "procedimiento para la preparacion de n-(2-piridiloxifenil)-n-benzoilureas substituidas".
ES512815A0 (es) "procedimiento para la preparacion de mandelonitrilos y derivados de acido mandelico".
ES509871A0 (es) "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas".
PT72435B (pt) Process for the preparation of 2-<2-(1,4-benzodioxanyl)>-2-imi-dazoline and salts thereof having pharmaceutical effect
AR230059A1 (es) Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo
ES508024A0 (es) "procedimiento para preparar derivados de dihidropiridina".
AR240924A1 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
IT1131682B (it) 2-(3,4,5-trimetossifenil)-tiazoli 4,5-bisostituiti e procedimento per la loro preparazione
DE3473443D1 (en) New amino derivatives of 2- (n-(2,2,5,5-tetramethyl-3-pyrrolin-or pyrrolidine-3-carbonyl))
NZ193236A (en) 2-(2,3-dihydro-1,4-benzodioxan-2-ylmethyl)amino)derivatives of 2-hydroxy-benzoic acid or benzamide
ES530574A0 (es) Procedimiento para preparar derivados de pirazol 1,5-a-piridina
MX5100E (es) Procedimiento para la produccion de 2-(2',2',-dihalovinil)-ciclobutanonas y 2-(2',2',2',-trihaloetil)-ciclobutanonas
ES546802A0 (es) Procedimiento para preparar derivados de 7-oxo-4-tia-1-aza- biciclo(3,2,0)hept-2-eno
BR8504148A (pt) Processo para a preparacao de fluoralcoxifenilsulfonil-guanidinas,composicoes herbicidas,aplicacao e processo para a preparacao de composicoes
AR241137A1 (es) "procedimiento para preparar beta-metilen-2 o 3-tiofenetanamina".
ES554603A0 (es) Procedimiento para preparar derivados de 3, 4-diazol
ES528900A0 (es) Procedimiento para la obtencion de n-(2-(1,2-dicloroviniloxi)-fenilsulfonil)-(tio) ureas
AR240826A1 (es) Procedimiento para preparar derivados de 7beta-(2-(2-aminotiazol-4-il)2-alcoxiiminoacetamido)-3-(1-piridinometil)-3-cefem-4-carboxilato
BR8504157A (pt) Processo para a preparacao de amidinoazois,composicoes herbicidas,aplicacao e processo para a preparacao de composicoes
ZA803050B (en) Salts of herbicidal 1,2,4-thiadiazolyl-5-urea derivatives and the use thereof
BR8504146A (pt) Processo para a preparacao de derivados de oxiguanidina,composicoes herbicidas,aplicacao,processo para a preparacao de composicoes e processo para a preparacao de derivados de 4,6-dimetil-2-oxiguanidinopirimidina
ES542379A0 (es) "procedimiento para preparar derivados de acido n-(fenilme- tiltio-3-oxo-1-propil)-aminoacetico".
ES509853A0 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
AR240935A1 (es) Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales.
BR8801794A (pt) Composicao fungicida e processo para a preparacao de derivados de 2-(o-alquila/substituido/)-2-tio-1,3,2-oxatiofosfolano